Literature DB >> 19542010

Burkholderia cenocepacia zinc metalloproteases influence resistance to antimicrobial peptides.

Cora Kooi1, Pamela A Sokol1.   

Abstract

Burkholderia cenocepacia secretes two zinc-dependent metalloproteases, designated ZmpA and ZmpB. Previously, ZmpA and ZmpB have been shown to cleave several proteins important in host defence. In this study, the ability of ZmpA and ZmpB to digest and inactivate antimicrobial peptides involved in innate immunity was examined. ZmpB but not ZmpA cleaved beta-defensin-1. ZmpA but not ZmpB cleaved the cathelicidin LL-37. Both enzymes cleaved elafin and secretory leukocyte inhibitor, which are antimicrobial peptides as well as neutrophil elastase inhibitors. Both ZmpA and ZmpB cleaved protamine, a fish antimicrobial peptide, and a zmpA zmpB mutant was more sensitive to protamine killing than the parental strain. ZmpA or ZmpB cleavage of elafin inactivated its anti-protease activity. The effect of ZmpA and ZmpB on the neutrophil proteases elastase and cathepsin G was also examined but neither enzyme was active against these host proteases. These studies suggest that ZmpA and ZmpB may influence the resistance of B. cenocepacia to host antimicrobial peptides as well as alter the host protease/anti-protease balance in chronic respiratory infections.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19542010     DOI: 10.1099/mic.0.028969-0

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  23 in total

1.  Prevalence, development, and molecular mechanisms of bacteriocin resistance in Campylobacter.

Authors:  Ky Van Hoang; Norman J Stern; Arnold M Saxton; Fuzhou Xu; Ximin Zeng; Jun Lin
Journal:  Appl Environ Microbiol       Date:  2011-01-28       Impact factor: 4.792

Review 2.  A decade of Burkholderia cenocepacia virulence determinant research.

Authors:  Slade A Loutet; Miguel A Valvano
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

Review 3.  Bacterial strategies of resistance to antimicrobial peptides.

Authors:  Hwang-Soo Joo; Chih-Iung Fu; Michael Otto
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-05-26       Impact factor: 6.237

Review 4.  Expanding Role of Type II Secretion in Bacterial Pathogenesis and Beyond.

Authors:  Nicholas P Cianciotto; Richard C White
Journal:  Infect Immun       Date:  2017-04-21       Impact factor: 3.441

Review 5.  Enterohemorrhagic and enteropathogenic Escherichia coli evolved different strategies to resist antimicrobial peptides.

Authors:  Jenny-Lee Thomassin; John R Brannon; Julienne Kaiser; Samantha Gruenheid; Herve Le Moual
Journal:  Gut Microbes       Date:  2012-08-16

6.  Use of Synthetic Hybrid Strains To Determine the Role of Replicon 3 in Virulence of the Burkholderia cepacia Complex.

Authors:  Kirsty Agnoli; Roman Freitag; Margarida C Gomes; Christian Jenul; Angela Suppiger; Olga Mannweiler; Carmen Frauenknecht; Daniel Janser; Annette C Vergunst; Leo Eberl
Journal:  Appl Environ Microbiol       Date:  2017-06-16       Impact factor: 4.792

Review 7.  Bacterial Evasion of Host Antimicrobial Peptide Defenses.

Authors:  Jason N Cole; Victor Nizet
Journal:  Microbiol Spectr       Date:  2016-02

Review 8.  Mammalian Neuropeptides as Modulators of Microbial Infections: Their Dual Role in Defense versus Virulence and Pathogenesis.

Authors:  Daria Augustyniak; Eliza Kramarska; Paweł Mackiewicz; Magdalena Orczyk-Pawiłowicz; Fionnuala T Lundy
Journal:  Int J Mol Sci       Date:  2021-04-01       Impact factor: 5.923

9.  Burkholderia cenocepacia type VI secretion system mediates escape of type II secreted proteins into the cytoplasm of infected macrophages.

Authors:  Roberto Rosales-Reyes; Daniel F Aubert; Jennifer S Tolman; Amal O Amer; Miguel A Valvano
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

Review 10.  Extreme antimicrobial peptide and polymyxin B resistance in the genus Burkholderia.

Authors:  Slade A Loutet; Miguel A Valvano
Journal:  Front Cell Infect Microbiol       Date:  2011-07-22       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.